Centerpoint Advisors’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-35
Closed -$1K 679
2022
Q4
$1K Hold
35
﹤0.01% 477
2022
Q3
$1K Hold
35
﹤0.01% 380
2022
Q2
$0 Hold
35
﹤0.01% 457
2022
Q1
$0 Hold
35
﹤0.01% 483
2021
Q4
$1K Hold
35
﹤0.01% 423
2021
Q3
$1K Hold
35
﹤0.01% 289
2021
Q2
$1K Hold
35
﹤0.01% 283
2021
Q1
$1K Hold
35
﹤0.01% 263
2020
Q4
$2K Hold
35
﹤0.01% 228
2020
Q3
$1K Buy
+35
New +$1.1K ﹤0.01% 223

Centerpoint Advisors's ONEM Position: Q1 2023 in Review

Centerpoint Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 35 shares — an estimated $1K sold.

Centerpoint Advisors first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $2K in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Centerpoint Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Centerpoint Advisors sold 35 1Life Healthcare shares in Q1 2023, an estimated $1K.
  • Centerpoint Advisors first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
  • Centerpoint Advisors's 1Life Healthcare position peaked at $2K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Centerpoint Advisors's 13F filing for Q1 2023, filed 3 May 2023.